NCT02813382

Brief Summary

Considering fast-track principles, an ideal spinal anesthetic should have minimal complications and above all fast recovery so reducing in-hospital stay. Between 1/8/2015 and 1/1/2016, a total of 101 patients attending the surgeon's practice with an umbilical or unilateral inguinal hernia and no contra-indications for surgery were included in this study. Patients were given 10.5mg bupivacaine (B-group), 40mg hyperbaric 2-chloroprocaïne (C-group) or 60mg prilocaïne (P-group), each with added sufentanil (2µg). Motor block was assessed using the Bromage scale. Sensory block was measured by determining the peak level dermatome. Intraoperative hemodynamic parameters were listed. Resolution of sensory and motor block, time to void and home readiness were defined as clinical endpoints.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
101

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Aug 2015

Shorter than P25 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2015

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2016

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

June 19, 2016

Completed
8 days until next milestone

First Posted

Study publicly available on registry

June 27, 2016

Completed
Last Updated

June 28, 2016

Status Verified

June 1, 2016

Enrollment Period

6 months

First QC Date

June 19, 2016

Last Update Submit

June 27, 2016

Conditions

Keywords

bupivacaineprilocaine2-chloroprocaine

Outcome Measures

Primary Outcomes (1)

  • Time to void

    Postoperative spontaneous voiding (\>200ml).

    up to 24hours after surgery

Secondary Outcomes (7)

  • in hospital time

    up to 24hours after surgery

  • time from spinal anesthesia to ready-to-cut

    an average of 3 minutes

  • time from spinal anesthesia to start of surgery

    an average of 3 minutes

  • time to T6

    1 hour

  • time to T10

    1 hour

  • +2 more secondary outcomes

Study Arms (3)

B-group

Spinal anesthesia was performed using 10.5mg bupivacaine with added sufentanil (2µg).

Drug: Bupivacaine

C-group

Spinal anesthesia was performed using 40mg hyperbaric 2-chloroprocaïne with added sufentanil (2µg).

Drug: Chloroprocaine

P-group

Spinal anesthesia was performed using 60mg prilocaïne with added sufentanil (2µg).

Drug: Prilocaine

Interventions

Spinal anesthesia was performed using 10.5mg bupivacaine with added sufentanil (2µg).

B-group

Spinal anesthesia was performed using 60mg prilocaïne with added sufentanil (2µg).

P-group

Spinal anesthesia was performed using 40mg hyperbaric 2-chloroprocaïne with added sufentanil (2µg).

Also known as: 2-chloroprocaine
C-group

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

105 consecutive patients undergoing elective unilateral open inguinal or umbilical hernia repair.

You may qualify if:

  • unilateral open inguinal or umbilical hernia repair
  • capable to understand the risks and commitment associated with the surgery and anesthesia

You may not qualify if:

  • concomittant surgical of non-surgical procedure
  • no agreement to informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (5)

  • Goldblum E, Atchabahian A. The use of 2-chloroprocaine for spinal anaesthesia. Acta Anaesthesiol Scand. 2013 May;57(5):545-52. doi: 10.1111/aas.12071. Epub 2013 Jan 16.

  • Lacasse MA, Roy JD, Forget J, Vandenbroucke F, Seal RF, Beaulieu D, McCormack M, Massicotte L. Comparison of bupivacaine and 2-chloroprocaine for spinal anesthesia for outpatient surgery: a double-blind randomized trial. Can J Anaesth. 2011 Apr;58(4):384-91. doi: 10.1007/s12630-010-9450-x. Epub 2011 Jan 4.

  • Forster JG. Short-acting spinal anesthesia in the ambulatory setting. Curr Opin Anaesthesiol. 2014 Dec;27(6):597-604. doi: 10.1097/ACO.0000000000000126.

  • Camponovo C, Fanelli A, Ghisi D, Cristina D, Fanelli G. A prospective, double-blinded, randomized, clinical trial comparing the efficacy of 40 mg and 60 mg hyperbaric 2% prilocaine versus 60 mg plain 2% prilocaine for intrathecal anesthesia in ambulatory surgery. Anesth Analg. 2010 Aug;111(2):568-72. doi: 10.1213/ANE.0b013e3181e30bb8. Epub 2010 Jun 7.

  • Akcaboy ZN, Akcaboy EY, Mutlu NM, Serger N, Aksu C, Gogus N. Spinal anesthesia with low-dose bupivacaine-fentanyl combination: a good alternative for day case transurethral resection of prostrate surgery in geriatric patients. Rev Bras Anestesiol. 2012 Nov-Dec;62(6):753-61. doi: 10.1016/S0034-7094(12)70176-9.

MeSH Terms

Conditions

Hernia, InguinalHernia, Umbilical

Interventions

BupivacainePrilocainechloroprocaine

Condition Hierarchy (Ancestors)

Hernia, AbdominalHerniaPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsInfant, Newborn, DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesHernia, Ventral

Intervention Hierarchy (Ancestors)

AnilidesAmidesOrganic ChemicalsAniline CompoundsAmines

Study Officials

  • Ben Gys, md

    AZ Sint Dimpna, Geel

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
md

Study Record Dates

First Submitted

June 19, 2016

First Posted

June 27, 2016

Study Start

August 1, 2015

Primary Completion

February 1, 2016

Study Completion

February 1, 2016

Last Updated

June 28, 2016

Record last verified: 2016-06